Santarpino, Giuseppe; Berretta, Paolo; Kappert, Utz; Teoh, Kevin; Mignosa, Carmelo; Meuris, Bart; Villa, Emmanuel; Albertini, Alberto; Carrel, Thierry P.; Misfeld, Martin; Martinelli, Gianluca; Phan, Kevin; Miceli, Antonio; Folliguet, Thierry; Shrestha, Malak; Solinas, Marco; Andreas, Martin; Savini, Carlo; Yan, Tristan; Fischlein, Theodor; ... (2020). Minimally Invasive Redo Aortic Valve Replacement: Results From a Multicentric Registry (SURD-IR). The annals of thoracic surgery, 110(2), pp. 553-557. Elsevier 10.1016/j.athoracsur.2019.11.033
Text
1-s2.0-S0003497520300151-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (146kB) |
BACKGROUND
Reoperation for aortic valve replacement can be challenging and is usually associated with an increased risk for complications and mortality. The study aim was to report the results of a multicenter cohort of patients who underwent minimally invasive reoperative aortic valve replacement with a sutureless or rapid-deployment prosthesis.
METHODS
From 2007 to 2018 data from 3651 patients were retrospectively collected from the Sutureless and Rapid-Deployment Aortic Valve Replacement International Registry. Of them, 63 patients who had previously undergone cardiac surgery represented the study population. In-hospital clinical and echocardiographic outcomes were recorded.
RESULTS
Mean age of the selected 63 patients was 75.3 ± 7.8 years and logistic EuroSCORE 10.1. Surgery was performed by ministernotomy in 43 patients (68.3%) and by anterior right thoracotomy in 20 (31.7%); 31 patients (49.2%) received the Perceval valve (Livanova PLC, London, UK) and 32 (50.8%) the Intuity valve (Edwards Lifesciences, Irvine, CA). Mean cross-clamp time was 57.8 ± 23.2 minutes and cardiopulmonary bypass time 95.0 ± 34.3 minutes. Neither conversion to full sternotomy nor in-hospital deaths occurred. Postoperative events were ischemic cerebral events in 3 patients (4.8%), need for pacemaker implantation in 2 (3.6%), bleeding requiring reoperation in 5 (8.9%), and dialysis in 1 (1.6%). Median intensive care unit stay was 1 day, and median length of hospital stay was 10 days. On echocardiographic evaluation 1 patient showed a significant postoperative aortic regurgitation.
CONCLUSIONS
Minimally invasive reoperative aortic valve replacement with a sutureless or rapid-deployment prosthesis is a safe and feasible treatment strategy, resulting in fast recovery and improved postoperative outcome with no mortality and an acceptable complication rate.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Heart Surgery |
UniBE Contributor: |
Carrel, Thierry |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1552-6259 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Paul Libera |
Date Deposited: |
15 Dec 2020 10:24 |
Last Modified: |
27 Feb 2024 14:28 |
Publisher DOI: |
10.1016/j.athoracsur.2019.11.033 |
PubMed ID: |
31954690 |
BORIS DOI: |
10.48350/149619 |
URI: |
https://boris.unibe.ch/id/eprint/149619 |